Prostate Cancer - Results from #20220

Racial disparities in an aging population: The relationship between age and race in the management of African American men with high-risk prostate cancer - Abstract July 4, 2014

Unidirectional barbed suture for vesicourethral anastomosis during laparoscopic radical prostatectomy - Abstract July 4, 2014

A pilot 'window of opportunity' neoadjuvant study of metformin in localised prostate cancer - Abstract July 4, 2014

Determination of the 120-day post-biopsy mortality rate - Abstract July 4, 2014

Diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition - Abstract July 4, 2014

Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer - Abstract July 4, 2014

PROSPECTIV-a pilot trial of a nurse-led psychoeducational intervention delivered in primary care to prostate cancer survivors: Study protocol for a randomised controlled trial - Abstract July 4, 2014

Point/counterpoint: Early detection of prostate cancer: Do the benefits outweigh the consequences? - Abstract July 4, 2014

Fusion of magnetic resonance imaging and real-time elastography to visualize prostate cancer: A prospective analysis using whole mount sections after radical prostatectomy - Abstract July 4, 2014

Early stage prostate cancer: Biochemical recurrence after treatment - Abstract July 4, 2014

Is active surveillance a safe alternative in the management of localized prostate cancer? Pathological features of radical prostatectomy specimens in potential candidates for active surveillance - Abstract July 4, 2014

Oncologic results, functional outcomes, and complication rates of transperitoneal robotic assisted radical prostatectomy: Single centre's experience - Abstract July 4, 2014

Prevention of prostate cancer: Outcomes of clinical trials and future opportunities - Abstract July 3, 2014

Metformin use and prostate cancer risk - Abstract July 3, 2014

Progress in the treatment of advanced prostate cancer - Abstract July 3, 2014

Randomized phase II study of nintedanib in metastatic castration-resistant prostate cancer postdocetaxel - Abstract July 3, 2014

Vaccine immunotherapy for prostate cancer: From mice to men - Abstract July 3, 2014

Real-time immune monitoring to guide plasmid DNA vaccination schedule targeting prostatic acid phosphatase (PAP) in patients with castration-resistant prostate cancer - Abstract July 3, 2014

Adding intensity-modulated radiotherapy to the pelvis does not worsen the adverse effect profiles compared to limited field radiotherapy in men with prostate cancer at 12-month follow-up - Abstract July 3, 2014

Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer - Abstract July 3, 2014

Page 1012 of 1435